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Abstract
Background: Proteins containing FERM domains comprise a diverse group of eukaryotic proteins
that bind membrane proteins and lipids. In doing so, they organise membrane microstructure, and
coordinate the disposition of signalling and cell adhesion complexes. In protein 4.1R,
phosphorylation adjacent to the FERM domain regulates its activity, and membrane mechanical
properties.
Results: A novel sequence domain has been detected in a subset of proteins that contain FERM
domains. This subset includes the true 4.1 proteins, some tyrosine phosphatases, rho-GEF proteins
and type II transmembrane proteins, as well as some uncharacterised FERM proteins. This FERM-
adjacent region is always closely proximate to the C-terminal of the FERM domain. This sequence
is likely to be folded with elements of α and β structure. The FERM-adjacent region of 4.1R contains
serine residues phosphorylated by PKC and PKA; these appear conserved in about half of all other
FERM-adjacent regions. Phylogenetic analyses indicate that all proteins containing a FERM-adjacent
region arose from a single ancestor after FERM domains had started to proliferate in genomes of
animals, plants and mycetozoa.
Conclusion: The FERM-adjacent region defines a subset of the FERM proteins in animals. The
conservation of motifs in this region that are potential substrates for kinases together with the
known regulatory phosphorylation of 4.1R in this region raises the possibility that the FERM-
adjacent region is a regulatory adaptation in this subset of the FERM proteins.
Introduction
FERM domains define the band 4.1 superfamily [1]. The
domain takes its name from the 4.1 (four point one) and
ERM (ezrin, radixin, moesin) proteins where it was first
discovered [1], but many metazoan cytoplasmic proteins
that associate with membranes contain FERM domains:
such proteins include merlin, talin, KRIT1, the uncoven-
tional myosins VIIA, X and XV, certain non-receptor pro-
tein tyrosine kinases (e.g. the FAK and JAK kinases) and
phosphatases (e.g. PTP-E1 and PTP-H1). A few examples
of FERM domains are also found in mycetozoa and
plants. This family is of great interest from several points
of view. Several members of the family are tumor suppres-
sors (4.1R, 4.1B, merlin) [2]. More generally, this family
carries functions that reflect many of the distinctive fea-
tures of eukaryotic – and most especially animal – life,
including tissue-specific signalling through organisation
of membrane domains, mechano-protection of mem-
branes from the stresses of animal movement and partici-
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pation in the formation of complex tissues through cell-
cell and cell-matrix junctions [3].
FERM domains have three-lobed 'cloverleaf' structures;
each lobe represents a compactly folded structure. Lobe A
(the most N-terminal) has a fold resembling ubiquitin;
lobe B (the central lobe) resembles acyl-CoA binding pro-
teins; and lobe C (the most C-terminal) has a fold related
to pleckstrin homology domain/phosphotyrosine-bind-
ing domain (PTB) [4-10]. The close packing of these
domains suggests they do not function independently,
but rather form a co-ordinated structure.
FERM domains bind a variety of protein and lipid ligands.
For example, in 4.1R, lobe A binds the anion exchanger
AE1 (band 3), lobe B binds the PDZ and guanylate kinase
protein p55 and lobe C binds glycophorin C [6]. The
motif YKRS in Lobe C is required for phosphatidylserine
(PS) binding to 4.1R; this motif is required for correct
intracellular targeting of 4.1R [11]. In the ERM proteins,
The FERM-adjacent (FA) region Figure 1
The FERM-adjacent (FA) region. An HMM for the FA region was used to search the Uniprot non-redundant database. The 
alignment shown here represents sequences detected with the HMM in human, D. melanogaster and C. elegans. The alignment 
was generated by aligning the sequences to the HMM using HMMALIGN. The sequences shown are all adjacent to the C-ter-
minal end of FERM domains, but not all FERM domains are adjacent to this sequence. Note the presence of a protein kinase A 
consensus sequence [KR][KR][X][ST] (boxed) in human protein 4.1R (41_HUMAN): the serine (asterisked) in this motif is a 
physiological PKA substrate. A PKC substrate site is also marked. In 4.1G (E41L2_HUMAN) another serine is phosphorylated 
in vivo (white asterisk). Secondary structure predictions generated are shown below the alignment. Jpred: E beta-strand; H 
alpha-helix. Disopred: * disorder. Jnet: B inaccessible to water. The proteins are grouped according to the classes shown in Fig. 
2.
41_HUMAN IPKSKFLALGSKFRYSGRTQAQTRQASALIDRPAPHFERTASKRASRSLDGAAAVD
E41L1_HUMAN PPPKGFLVMGSKFRYSGRTQAQTRQASALIDRPAPFFERSSSKRYTRSLDGAEFSR
E41L2_HUMAN PPKAKFLTLGSKFRYSGRTQAQTRQASTLIDRPAPHFERTSSKRVSRSLDGAPIGV
E41L3_HUMAN APPKKFLTLGSKFRYSGRTQAQTRRASALIDRPAPYFERSSSKRYTRSLDG-EVGT
41DROME SKSKMFPVFGSTYRYKGRTQAESTNTPVDRTPP---FNRTLSRLTSRSMDALALAE
Q9TVI9 THKSFFNFGSQRFRYQGRTQFQTKIASQMFDKPS--VDRAPSMSQPTAENQKLQTL
Q86WP8 VSSSKIFFKGSRFRYSGKVAKEVVEASSKIQREPPEVHRANIRSS-HSLNKQLIIN
Q8NBG4 VSSSNLFFKGSRFRYSGRVAKEVMESSAKIKREPPEIHRAGMRSCP-SITHGPRLS
Q9VKY7 ISGGGFFSWGTKFRYTGRTEREILTENINALRE--QNNSNSSRKAS-SVPATPSSP
P91092 KPRIPLLSRGSTFRF---PSKRVYREIEEEDSK-SIFDKS--IMET-AVMNETTTS
PTN4_HUMAN NFFAHYFTLGSKFRYCGRTEVQSVQYGKEKANK-DRFARSPSKPLARKLMDWEVVS
Q9W0R3 HRLSRFISLGSKFYYSGRTELQAVQESKQRGRI-HKFVRSPSKRLL--AAGGVGTS
PTP1_CAEEL TPQRKVFNFGSKFRYSGRTEYQTLEENEHRKSAGHRFHRSLSKSSFRSTFSGNTQS
Q9Y4F1 KPKPVLFSRGSSFRFSGRTQKQVLDYVKEGGHK-KVFERKHSKIHSRSLASQPTEL
Q91VS8 KAKAVFFSRGSSFRYSGRTQKQLVDYVKDGGMK-RIYERRHSKTRTHALTVDLPKQ
Q9VN68 RRKTRVLSRGSSFRYSGKTQKQIIEFVRENYVK-RQFQRY--KTNSS---------
E41LA_HUMAN RKLSKFGSIRYKHRYSGRTALQMSRDLSIQLPRPDQVTRSRSKTYPRIAQTQPAES
E41LB_HUMAN SNRSDFIRLGSRFRFSGRTEYQATHGSRLRRTS---FERKPSKRYPRHSTFKASNP
E41L5_HUMAN SHRSGFIRLGSRFRYSGKTEYQTTKTNKARRST---FERRPSKRYSRTLQMKACAT
Q6ZUT3 KPKTLLCSKGSSFRYSGRTQRQLLEYGRKGRLK-SLFERKHYRQC-RSSPDLLSDV
Q9V9Y3 SHAADLFQLGSRFRHS-RPDKQTEKDALSAGRSPPAFTRTPSKRQPRVIDDFFNSN
Q9VFU8 SARQNFFRMGSRFRYSGRTEFQTTQQSRARRTV---FERRPSRFASRQSHLLRERQ
Q9GP93 NRKIQFFRLGSTFKYRGRTEYETIHGARLSRRQSC-FERRPSRYGPRQSHVTNAQI
O17905 KKETRFISKGSSFRYHGRTQKQLIDYVREHHKR-REFTRPL-RSAARKGTYSSTYG
Consensus/65% p.pstabsbGS+FRYSGRTpbQshptspbbppt...FcRs.S+ptsRshsst.sts
jpred -----EEEE--EEE----HHHHHHHHHHH---------------------------
Disopred *************..........*..******************************
Jnet_25 -----BB-BBB-BBB-B-BBBBB---B------B--B----BB-BBB-B-------
* 
(a)
(b)
(c)
(d)
(e)
*
PKC PKA
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the head group of PIP2 binds a basic cleft between lobes A
and C; this binding displaces the ERM tail from the FERM
domain [4] thus unmasking the binding site for cell adhe-
sion molecules (such as ICAM1-3 and L1) on lobe C [12].
The first observation of what is now known as the FERM
domain came when Leto et al. [13] subjected 4.1R to lim-
ited chymotryptic proteolysis. The FERM domain was
released as a 30 kDa fragment. Another protease-resistant
fragment released in this experiment was 16 kDa. This
region lies between the FERM domain and another impor-
tant functional domain, the spectrin-actin binding
domain. The 16 kDa fragment contains residues phos-
phorylated by PKA and PKC [14,15]. Importantly, PKC
phosphorylation of a serine residue in this region modu-
lates membrane mechanical properties by controlling the
activities of both the FERM and the spectrin-actin-binding
domain [16].
Mammals have four "true" 4.1 proteins: 4.1R, 4.1N, 4.1G
and 4.1B. Sequence alignment revels considerable iden-
tity between the N-terminal half of their 16 kDa regions,
although the C-terminal halves are much less conserved
[17]. Here, I investigate the nature of the conserved part of
the 16 kDa region. I report that sequences strongly similar
to the conserved part of the 16 kDa region are present in
a subset of the 4.1 superfamily. This region seems to form
a discrete FERM-adjacent region, with the potential to reg-
ulate the activities of its neighbouring FERM domain.
Results and discussion
Identification of the FERM-adjacent region
The FERM domain in human protein 4.1R [Swiss-
Prot:41_HUMAN] is now defined as residues 285–488 by
X-ray crystallography [PDB:1GG3] [6]. The 16 kDa frag-
ment lies directly adjacent to the FERM domain: residues
494–614.
Sequence alignment of the four mammalian "true" 4.1
proteins, 4.1R, 4.1B, 4.1G and 4.1N, reveals that a high
level of sequence identity extends beyond the end of the
FERM domain, and into the 16 kDa region [17]. To
explore this further, I compared the 16 kDa region of
human 4.1R with the sequences of other mammalian
4.1R, 4.1G, 4.1N and 4.1B proteins available in the Uni-
prot Knowledgebase (Swis-Prot/Trembl) [18]. This
revealed a region of strong conservation over approxi-
mately 60 amino acid residues at the N-terminus of the 16
kDa region. 60 amino acids is a large enough region to
fold, and is similar in size to known folding structures
such as the SH3 domain.
To explore the prevalence of this region, the aligned
sequences were used to make a hidden Markov model
(HMM) that can be used as a profile of the alignment for
database searching. An HMM search of Uniprot SPTR
revealed further proteins with analogous sequences. These
sequences were retrieved, and incorporated into the align-
ment with the true 4.1 proteins. This expanded alignment
was used to generate a new HMM which was used to re-
search the database. A third iteration of align sequences/
build HMM/search database was performed. The HMM
from this reveals no more significant database hits. The
full list of sequences detected in given in Table 1 (Addi-
tional file 1). Some representative sequences detected by
the expanded HMM are shown in Fig. 1.
Examples of classes of proteins containing the FA region Figure 2
Examples of classes of proteins containing the FA 
region. The figure shows the modular organisation of FA 
region proteins in schematic outline. The proteins all contain 
FERM domains in their N-terminal region (although splice 
variation at certain N-termini can add extra sequence 
upstream of the FERM domain). On the C-terminal side of 
the FERM and FA regions are diverse sequences. Examples 
shown are as follows. (a) The true 4.1 proteins have a C-ter-
minal domain (CTD) that binds receptors; and in mammals a 
spectrin-actin binding domain (SAB) promotes the binding of 
spectrin to actin. There are four such in vertebrate genomes, 
and one such in invertebrate genomes. (b) A group of poorly 
characterised proteins (two in vertebrate genomes, one in 
invertebrates) have FERM and FA regions, plus transmem-
brane segments in their C-terminal regions. They have no N-
terminal signal sequences, and appear to be Type II mem-
brane proteins. (c) The non-receptor tyrosine phosphatase 
protein PTP-MEG1 in mammals, PTP-MEG (split central com-
plex) in fly and protein-tyrosine phosphatase 1 in worm are 
non-receptor tyrosine phosphatases localised at membranes; 
they have roles in control of cellular proliferation and con-
trol of interaction with extracellular matrix. Notably, the FA 
region was not found in the other FERM domain phos-
phatases PTPH1, PTP-E1 and PTP36. (d) CDEP is a GEF for 
Rho family GTPases. The FA region is also found in the 
related FARP2 gene product. (e) A variety of other proteins 
lack further domains recognised by SMART or Pfam. These 
include Band 4.1-like protein 5 and NBL-4.
FERM FA PH PH RhoGEF
FERM FA SAB CTD
FERM FA PDZ PTPc
TM
FERM FA
FERM FA
(a)
(b)
(c)
(d)
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Strikingly, all the sequences recognised by the HMM are
immediately adjacent to a FERM domain. However, they
are clearly distinct from FERM domains in that the HMM
does not recognise the sequence of any known FERM
domain. The HMM detects no proteins whose structures
are represented in the Protein Databank. For simplicity, I
shall refer to sequences recognised by the HMM as FERM-
adjacent (FA) regions.
The HMM hits include only a minority of members of the
4.1 superfamily. The hits include: (a) the "true" 4.1 pro-
teins; (b) a poorly characterised group of proteins with
signal-anchor transmembrane sequences close to their C-
termini; (c) a subset of the non-receptor tyrosine phos-
phatases (e.g. PTP1 of C. elegans, and human PTN4); (d)
CDEP, a GEF for Rho family GTPases; (e) a number of
proteins with only FERM and FA regions, including NBL4
[Swiss-Prot:E41LA_HUMAN] and E41L5 [Swiss-
Prot:E41L5_HUMAN]. The domain structures of these
proteins are summarised in Fig. 2.
All the sequences detected are in animal proteins with one
exception. [Trembl:Q8GUI3] is an Arabidopsis thaliana
hypothetical protein which contains a FERM domain, and
a weak hit (E = 0.00042) is detected adjacent to this. No
other plant or mycetozoan protein is detected.
Importantly, many well-characterised members of the
band 4.1 superfamily are not detected by the HMM: in
particular the ERM proteins, merlin, talin, unconven-
tional myosins and non-receptor protein tyrosine kinases
were not found.
A more extended alignment of several FERM proteins that
contain the FA region in comparison with representative
proteins that do not contain the FA region illustrates the
limits of the FA region. Additional file 2 shows the
sequences of several human proteins aligned to the
sequence of 4.1R Lobe B of the FERM domain through the
whole 16 kDa sequence. Note that the FA region is
detected as a discrete sequence region corresponding to
the N-terminal half of the 16 kDa fragment in class A-E
proteins, and that no sequence similarity is detected in
other proteins.
Is the FA region folded?
FA regions seem likely to be compactly folded since the
4.1R 16 kDa fragment is resistant to chymotrypsin [13],
despite containing several possible substrate residues (see
sequence 41_HUMAN in Fig. 1).
To predict secondary structures, the alignment of all FAs
was submitted to JPRED; 4.1R sequence was also submit-
ted to PSI-Pred and Disopred. An α-helix and β-strand and
a certain amount of disordered structure are predicted,
and the most conserved part of the sequence in the FA
alignment is predicted to be buried (annotated on Fig. 1).
But the structure cannot be predicted with certainty,
because the HMM recognises no sequences of proteins of
known structure in the Protein Data Bank. Furthermore,
the fold-recognition programmes PSI-Pred and 3D-PSSM
do not detect a known fold.
A single evolutionary event links FERM and FA proteins
The presence of a single FA region in a subset of all FERM
domain proteins raises the question of their evolutionary
origin. Do these proteins derive from a single ancestral
FERM protein that acquired an FA region at some point
after FERM domains started to multiply in animal, plant
and mycetozoan genomes? If the answer to this question
is "yes", then the FA-containing subset of the superfamily
should have FERM domains more closely related to each
other than to non-FA-containing proteins.
To address this, a structurally well-conserved part of the
FERM domain, lobe B, was subjected to phylogenetic
analysis. To define sequences homologous to lobe B, the
sequences of lobe B that are defined structurally in the
PDB (from protein 4.1R, merlin, ezrin, radxin, moesin,
talin) were used to make another HMM specific for lobe
B. Searching Uniprot with this HMM defined lobe B in the
majority of known members of the superfamily. The
sequences of lobe B were then aligned to the HMM and
their phylogeny analysed. Parsimony, maximum likeli-
hood and neighbour joining trees were constructed. Fig. 3
shows a consensus maximum likelihood tree generated by
Phylip from lobe B sequences that had been bootstrapped
100 times. In each case, the FERM/FA proteins were found
to derive from a single node. This supports the hypothesis
that FERM/FA region proteins arose from a single ancestor
that acquired a FA region adjacent to its FERM domain.
Identical conclusions can be drawn from the maximum
likelihood and neighbour joining trees (not shown). Note
that groups (a) -(e) from Fig. 2 largely cluster together in
this tree. As might be predicted, the overall domain struc-
tures of the proteins are mirrored in the phylogeny of the
FERM domains.
Interestingly, the phosphatase PTN3 [Swiss-
Prot:PTN3_HUMAN] does not contain an FA region, yet
appears in the FA group. Direct alignment of this sequence
with that of the related phosphatase PTN4 [Swiss-
Prot:PTN4_HUMAN] leaves a gap where the FA region
would be (see Additional file 2); furthermore, probing all
possible translations of the genomic sequence of PTN3
with the FA region HMM reveals no FA sequence that
might be expressed in splice variants. Maximum parsi-
mony and neighbour joining analyses (not shown) sup-
port the positioning of PTN3 in the FA cluster. It seemsBMC Genomics 2006, 7:85 http://www.biomedcentral.com/1471-2164/7/85
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most likely that PTN3 has lost the FA region present in the
common ancestor of PTN3 and PTN4.
PKC and PKA phosphorylation sites
It has long been established that protein kinases A and C
phosphorylate the 16 kDa portion of erythrocyte 4.1R
[14,15]. Protein kinase C regulates the membrane binding
activity of the 4.1R FERM domain [15,19-21]. Recently
Manno et al. [16] have shown that PKC phosphorylates
ser-312 in erythrocyte 4.1R (isoform 3 [IPI:IPI00218698];
the equivalent sequence number in [Swiss-
Prot:41_human] is ser-521). The site in the 16 kDa por-
tion phosphorylated by PKA is ser-331[14]. Both these
residues are part of the FA region.
Ser-312 is not in a known PKC consensus, so it is difficult
to predict if equivalent residues in other proteins will be
PKC substrates. However, Fig 1 indicates that about half of
the FA region proteins have ser at equivalent positions in
the alignment.
Ser-331 is in the protein kinase A substrate motif, [KR]
[KR]X [ST], and this is conserved in all mammalian "true"
4.1 proteins. It is also conserved in some of the group that
lacks known functional domains in their C-termini (e.g.
E41L5) and in some of the group of transmembrane pro-
teins (see Fig. 1).
Protein 4.1G [Swiss-Prot:E41L2_human] is also phospho-
rylated in vivo in the FA region at ser-550 [22]. The kinase
that catalyses this phosphorylation has not been identi-
fied. Representatives of each of groups (a)-(e) contain ser
or thr at this point in the alignment, indicating that this
too is a candidate site for phosphorylation in other FA
proteins.
Conclusion
The FA sequence region described here is in all cases
immediately adjacent to FERM domains. Based on the
chymotrypsin resistance of the 16 kDa 4.1R fragment, and
secondary structure predictions, it seems likely that FA
Phylogenetic tree of lobe B of FERM domains Figure 3
Phylogenetic tree of lobe B of FERM domains. This tree was produced by Maximum Likelihood (Phylip proml) analysis of 
a non-redundant selection of FERM domain lobe B sequences. The grey shading lies over proteins that contain both FERM and 
FA regions: proteins outside the shading contain FERM domains, but not the FA. FERM/FA region proteins are colour coded to 
indicate their class of sequence as given in Fig 2: (a) red (b) orange (c) green (d) blue (e) purple.
MERH_DROME
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MOES_MOUSE
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regions are folded. The FA region of 4.1R is phosphor-
ylated in vivo by PKA and PKC. The latter phosphoryla-
tion is especially important in the red cell, since
phosphorylation of ser-312 controls the activity of the
adjacent FERM and spectrin-actin binding domains which
in turn controls the mechanical properties of the red cell
membrane [16]. Since representatives of all the five
groups of FA proteins contain ser/thr at sites equivalent to
those phosphorylated in the 4.1R and 4.1G FA regions,
the possibility arises of a general role of the FA region in
regulating the activities of their neighbouring FERM
domain.
Methods
Sequences were retrieved from the UniProt Knowledge-
base via the European Bioinformatics Institute (EBI) [23].
BLAST analyses were done with either the BLAST2 server
at EBI [24] or the BLAST server at the National Center for
Biotechnology Information [25]. The HMMER package
[26,27] was used for hidden Markov model analysis; it
was run either locally or via a server made available by the
Medical Research Council's Rosalind Franklin Centre for
Genomics Research [28]. Alignments of sequences to
HMMs were done using HMALIGN; alignments were dis-
played using Chroma [29]. Secondary structure predic-
tions were made using JPRED [30,31]. PSI-Pred [30,32]
and Disopred [33,34]. Fold recognition was done using
the PSI-PRED and 3D-PSSM [35,36] servers. For phyloge-
netic analyses, the Phylip package [37] was used.
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